Australia won't be 'cheer squad' for Hamas: PM

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Sky News AU
9 minutes ago
- Sky News AU
Israeli minister threatens Palestinian prisoner during jail visit
Israel's national security minister has been criticised after a video posted on social media showed him confronting a prominent Palestinian prisoner in jail. It's believed Itamar Ben-Gvir, an outspoken member of Benjamin Netanyahu's cabinet, entered the solitary confinement cell of Palestinian leader Marwan Barghouti. This comes as Israel's Finance Minister Bezalel Smotrich has announced plans to build more than 3,000 new homes in the West Bank, which he says will bury any idea of a Palestinian state.


7NEWS
39 minutes ago
- 7NEWS
7NEWS The Issue: Why Trump's latest veiled threat could spell trouble for the pride of Australia
It was a telling measure of the value Australians put in the country's 77-year-old Pharmaceutical Benefits Scheme. In mid March, as the Albanese government looked for an issue to give it impetus for a soon-to-be-called election, it turned to the PBS; loved in Australia - and loathed by Pharmaceutical makers abroad - for delivering medicines at little more than one quarter the cost paid by Americans. Prime Minister Albanese announced, if reelected, he'd reduce the scheme's cap on prescriptions, from $31.60 to just $25. Opposition leader Peter Dutton immediately backed the plan. 'We support affordable medicines,' he told radio 2GB. On complaints from US pharmaceutical companies about the PBS, the Prime Minister seized on the chance for a fight. The PBS, he said was 'a monument to the fairness at the heart of Australian life and we don't negotiate our values.' The PBS is political gold. Supporting it is a 'no brainer' for a federal politician. Yet, five months on that threat from the US, has only intensified and it may yet test Australia's love for the scheme. For President Donald Trump, high prescription drug costs in America have become a cause. Loading content... Last month, the White House announced the President had written to 17 drug company CEOs demanding guarantees 'they will not offer other developed nations better prices for new drugs than prices offered in the United States.' According to a Trump White House fact sheet, 'Americans are subsidising drug-manufacturer profits and foreign health systems.' The statement did not mention Australia's PBS, but if the White House staff had wanted an example, it would have been an obvious candidate. 'The PBS is a cornerstone of our Medicare system' according to Medicines Australia CEO, Liz de Somer, though that's where her applause for the scheme ends. Medicines Australia is the industry body representing many of the same pharmaceutical giants now targeted by the Trump White House. According to Liz de Somer 'we're lagging behind other countries in the time it takes to make new medicines available on the PBS.' 'We are now taking an average of 466 days for a new innovative medicine to be listed on the PBS, and that's after it's already been deemed safe and effective by the Therapeutic Goods Administration.' 'We know these drugs are safe, we know they're effective, but the government has not yet decided to purchase them and make them subsidised for patients. They take too long.' Medicines Australia wants the 466 days average drug listing time, reduced dramatically - to just sixty days. That would likely mean dramatically reducing the time taken by the government and companies to negotiate a price for their medicines. The end result could easily be a bigger bill for the Australian taxpayer. Currently, the PBS costs about $14 billion a year to run. Of course, there is a human cost to delaying approval for medicines. Medicines Australia points to the 'many, many cancer medicines that are not available for patients' in Australia. According to Liz de Somer: 'We are getting one in four innovations listed on our PBS at the moment. That's not good enough.' 'We know that people are waiting for these medicines. We know that they can see they're available in other countries, and they don't understand why they're not made available here.' There is an obvious profit motive for pharmaceutical companies in getting listed sooner and selling their product more quickly, but delays in the system have a human cost. The Albanese government is currently considering recommendations to reform the scheme including measures designed to speed the process.

The Age
2 hours ago
- The Age
Melania Trump writes private letter to Vladimir Putin
Trump revealed earlier this year that his wife had been influential in pushing him to secure peace in Ukraine. 'My conversations with him [Putin] are always very pleasant. I say, isn't that a very lovely conversation? And then the missiles go off that night,' Trump said at the White House last month. 'I go home, I tell the first lady: 'I spoke with Vladimir today. We had a wonderful conversation.' She said: 'Really? Another city was just hit.'' The Slovenian-born first lady, who grew up in the former Yugoslavia, has been supportive of Ukraine since Putin launched his invasion in 2022. Shortly after the war started, she called on her social media followers to donate to the Red Cross and said it was 'heartbreaking and horrific to see innocent people suffering'. Ukrainians and some US Republicans have praised her for seemingly influencing Trump to push Putin for peace. 'Well, I'm glad that the president has pivoted on Ukraine,' Don Bacon, a Republican congressman, said in an interview after the president threatened to impose secondary sanctions on Russia last month. 'I think we owe Melania some thanks here. Even the president said that his wife reminds him every day that Russia is bombing Ukrainian cities every night,' he continued.